Overview
Phesgo is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) for use with chemotherapy to treat adults with early-stage HER-2 positive breast cancer. Phesgo is also approved… read more
Overview
Lynparza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer. Lynparza may be prescribed for either hormone receptor-positive or -negative cases,… read more
Overview
Xeloda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer. Xeloda may be prescribed either as monotherapy (on its own) in cases resistant to… read more
Overview
Nerlynx is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as adjuvant (post-surgery) treatment for adults with early stage breast cancer in which HER2 is overexpressed or amplified.… read more
Overview
Ogivri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name,… read more
Overview
Herceptin Hylecta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjuvant treatment for metastatic breast cancer in cases where tumors overexpress the HER2 protein and one… read more
Overview
Tecentriq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with triple-negative breast cancer (TNBC) in cases where surgery is not an option and the tumor is… read more
Overview
Ellence is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with axillary node tumor involvement after removal of primary breast cancer. Ellence may be also referred… read more
Overview
Methotrexate is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat severe rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and severe psoriasis. Methotrexate… read more